Michele Wible, MS

Pfizer WW Research & Development
Collegeville, Pennsylvania, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 2893 A - Efficacy and Safety of Aztreonam-Avibactam for the Treatment of Serious Infections Due to Gram-Negative Bacteria, Including Metallo-β-Lactamase-Producing Pathogens: Phase 3 REVISIT Study

  Saturday, October 14, 2023
  2:35 PM – 2:45 PM US ET